Home » ImmunoGen: Roche Issued Favorable Update on T-DM1 Approval Plans
ImmunoGen: Roche Issued Favorable Update on T-DM1 Approval Plans
ImmunoGen, Inc. announced Thursday that Roche has provided a favorable update related to its plans to apply for marketing approval of trastuzumab-DM1,
or T-DM1, in the US.
RTTNews
RTTNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May